• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    UL Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

    10/28/25 5:20:25 PM ET
    $ULS
    Precision Instruments
    Health Care
    Get the next $ULS alert in real time by email
    uls-20251028
    false000190144000019014402025-10-282025-10-28





    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________________
    FORM 8-K
    ___________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (date of earliest event reported): October 28, 2025
    ___________________________________
    UL Solutions Inc.
    (Exact name of registrant as specified in its charter)
    ___________________________________

    Delaware
    (State or other jurisdiction of
    incorporation or organization)
    001-42012
    (Commission File Number)
    27-0913800
    (I.R.S. Employer Identification Number)
    333 Pfingsten Road
    Northbrook, Illinois 60062
    (Address of principal executive offices and zip code)
    (847) 272-8800
    (Registrant's telephone number, including area code)
    ___________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol
    Name of each exchange on which registered
    Class A Common Stock, par value $0.001 per shareULSNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐









    Item 1.01. Entry into a Material Definitive Agreement
    On October 28, 2025, UL Solutions Inc. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”), by and among the Company and certain of its non-U.S. subsidiaries as co-borrowers (collectively, the “Borrowers”), Bank of America, N.A., as administrative agent, and the lenders party thereto.

    The Credit Agreement provides for a $1.0 billion senior unsecured five-year multi-currency revolving facility (the “2025 Credit Facility”), with a $25 million sub-limit for the issuance of letters of credit. The Credit Agreement includes an accordion feature permitting an increase in the 2025 Credit Facility by an aggregate amount of up to $500 million, subject to the consent of any lenders providing such increase, the absence of any default or event of default and entry into customary documentation with respect to such increase. The Borrowers’ obligations (other than the Company’s) under the Credit Agreement are guaranteed by the Company.

    On October 28, 2025, the Company borrowed $291 million under the 2025 Credit Facility. The initial borrowing was used to refinance the outstanding amounts under that certain Credit Agreement, dated as of January 11, 2022, by and among the Company, UL LLC, the lenders party thereto and Bank of America, N.A., as administrative agent (as amended, the “2022 Credit Facility”). Additional amounts, if any, borrowed under the 2025 Credit Facility are anticipated to be used for general corporate purposes.

    Borrowings under the 2025 Credit Facility bear interest at a rate per annum equal to, at the applicable Borrower’s option, (a) a specified benchmark rate for the applicable currency (which, in the case of U.S. Dollar loans, shall be the Term SOFR or Daily SOFR (in each case as defined in the Credit Agreement), at the applicable Borrower’s option), plus a margin that ranges from 0.875% to 1.375% per annum or (b) for U.S. Dollar loans made to the Company only, a base rate (which is equal to the highest of (i) the Bank of America prime rate, (ii) the U.S. federal funds rate plus 0.500% per annum, or (iii) the Term SOFR or Daily SOFR rate plus 1.00%) plus a margin that ranges from 0.000% to 0.375% per annum. The 2025 Credit Facility matures on October 28, 2030 and may be prepaid without fees or penalties, subject to reimbursement of the lenders’ customary breakage and redeployment costs in applicable cases.

    The 2025 Credit Facility also includes a financial covenant, tested quarterly, which requires the Company to maintain a consolidated net leverage ratio of not greater than 3.5 to 1.0, calculated on a consolidated basis for each consecutive four fiscal quarter period, with an increase in the maintenance level to 4.0 to 1.0 for each of the four test periods immediately following any permitted acquisition that involves the payment of aggregate consideration in excess of $100 million, subject to a two fiscal quarter rest period between increases for separate acquisitions. The calculation of the consolidated net leverage ratio permits the netting of up to $250 million of unrestricted cash from funded debt.

    The 2025 Credit Facility includes customary representations and warranties, covenants and events of default, subject to certain customary exceptions, materiality thresholds and grace periods. The covenants include, among other things, financial reporting, maintenance of line of business, notices of default and other material changes, as well as limitations on investments and acquisitions, mergers and transfers of all or substantially all assets, dividends and distributions, burdensome contracts with affiliates, liens and indebtedness. Future borrowings under the 2025 Credit Facility are subject to the satisfaction of customary conditions, including the absence of any default or event of default and the accuracy of representations and warranties.

    The description of the Credit Agreement contained herein is qualified in its entirety by reference to the full text of the agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K.
    Item 1.02. Termination of a Material Definitive Agreement
    On October 28, 2025, in connection with the entry into the Credit Agreement described above, the Company repaid in full all indebtedness and other obligations outstanding under, and terminated, the 2022 Credit Facility.
    Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 2.03 by reference.
    Item 3.03. Material Modification to Rights of Security Holders
    The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 3.03 by reference. Pursuant to the terms of the Credit Agreement, the Company’s ability to pay cash dividends on shares of its common stock will be subject to the Company being in compliance with the financial covenant set forth in the Credit Agreement (subject to certain additional exceptions specified in the Credit Agreement).







    Item 9.01. Financial Statements and Exhibits
    (d) Exhibits
    Exhibit NumberDescription
    10.1*
    Credit Agreement, dated as of October 28, 2025, among UL Solutions Inc., UL GmbH, UL International-Singapore Private Limited, Underwriters Laboratories Holdings B.V., UL International (UK) Limited, Bank of America, N.A., as administrative agent, and the lenders party thereto
    104Cover page interactive data file (embedded with the inline XBRL document)
    *Exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the omitted exhibits or schedules to the SEC on a confidential basis upon request.
    Signature
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
    UL Solutions Inc.
    Date: October 28, 2025By:/s/ Ryan D. Robinson
    Ryan D. Robinson
    Executive Vice President and Chief Financial Officer


    Get the next $ULS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ULS

    DatePrice TargetRatingAnalyst
    11/5/2025$84.00Overweight → Neutral
    Analyst
    5/14/2025$71.00Buy → Neutral
    Citigroup
    10/7/2024$60.00Buy
    Citigroup
    7/12/2024$41.00 → $46.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ULS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UL Solutions Inc. downgraded by Analyst with a new price target

    Analyst downgraded UL Solutions Inc. from Overweight to Neutral and set a new price target of $84.00

    11/5/25 7:29:40 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. downgraded by Citigroup with a new price target

    Citigroup downgraded UL Solutions Inc. from Buy to Neutral and set a new price target of $71.00

    5/14/25 8:58:56 AM ET
    $ULS
    Precision Instruments
    Health Care

    Citigroup resumed coverage on UL Solutions Inc. with a new price target

    Citigroup resumed coverage of UL Solutions Inc. with a rating of Buy and set a new price target of $60.00

    10/7/24 8:45:25 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UL Solutions Inc. Reports Strong Third Quarter 2025 Results

    Third Quarter 20251 Strong revenue growth of 7.1% to $783 million, including 6.3% organic growth Net income of $106 million increased 12.8%, Adjusted Net Income of $119 million increased 14.4%. Net income margin of 13.5% increased 60 basis points Diluted earnings per share of $0.49 increased 11.4%, Adjusted Diluted Earnings Per Share of $0.56 increased 14.3% Adjusted EBITDA of $217 million increased 18.6%, Adjusted EBITDA margin of 27.7% expanded 270 basis points Announcing a restructuring initiative to reduce expenses Strengthening full-year financial outlook UL Solutions Inc. (NYSE:ULS), a global safety science leader in independent third-party testing, inspection and certif

    11/4/25 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Launches Landmark Artificial Intelligence Safety Certification Services

    New AI safety certification aims to build public trust and enable the responsible adoption of beneficial AI technologies. UL Solutions Inc. (NYSE:ULS), a global leader in safety science, today announced the launch of artificial intelligence (AI) safety certification services, enabling comprehensive assessments for evaluating the safety of AI-powered products. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251102590835/en/UL Solutions has launched AI safety certification services, enabling comprehensive assessments for evaluating the safety of AI-powered products. AI is rapidly transforming everyday life, powering everything fr

    11/3/25 8:35:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Launches New ECOLOGO® Certification for Industrial Products, Advancing Environmental Leadership in Manufacturing

    New ECOLOGO certification for energy and industrial automation equipment helps manufacturers validate sustainability claims through science-based standards UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced its new ECOLOGO certification program for energy and industrial automation equipment, such as circuit breakers and safety switches, that helps manufacturers advance the sustainability of industrial equipment and meet stakeholder demands. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251027166525/en/UL Solutions announced its new ECOLOGO certification program for energy and industrial a

    10/27/25 8:05:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Shannon James M

    4 - UL Solutions Inc. (0001901440) (Issuer)

    10/6/25 4:45:18 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 4 filed by Director Susman Sally

    4 - UL Solutions Inc. (0001901440) (Issuer)

    9/10/25 6:15:43 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 4 filed by Director Gottschalk Marla C

    4 - UL Solutions Inc. (0001901440) (Issuer)

    9/10/25 6:15:37 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by UL Solutions Inc.

    SCHEDULE 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/5/25 11:49:28 AM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 10-Q filed by UL Solutions Inc.

    10-Q - UL Solutions Inc. (0001901440) (Filer)

    11/4/25 4:46:32 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits

    8-K - UL Solutions Inc. (0001901440) (Filer)

    11/4/25 7:00:53 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Leadership Updates

    Live Leadership Updates

    View All

    UL Solutions Breaks Ground on Global Fire Science Center of Excellence in Illinois

    The advanced fire safety testing and R&D facility will be dedicated to identifying, evaluating and mitigating fire risks. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory investments to date, helping to reduce fire risks globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826231103/en/UL Solutions has announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory i

    8/26/25 5:30:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Names New Chief Legal Officer

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

    3/11/25 9:15:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Names Chief Business Operations and Innovation Officer

    Alex Dadakis to join UL Solutions leadership team in newly created role UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Alex Dadakis as Executive Vice President, Chief Business Operations and Innovation Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205299962/en/UL Solutions announced the appointment of Alex Dadakis as Executive Vice President, Chief Business Operations and Innovation Officer, effective Jan. 27, 2025. (Photo: Business Wire) Dadakis, who most recently served as Senior Vice President, Global Head of Strategy and Corporate Development at Germany-ba

    12/5/24 4:15:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Financials

    Live finance-specific insights

    View All

    UL Solutions Inc. Reports Strong Third Quarter 2025 Results

    Third Quarter 20251 Strong revenue growth of 7.1% to $783 million, including 6.3% organic growth Net income of $106 million increased 12.8%, Adjusted Net Income of $119 million increased 14.4%. Net income margin of 13.5% increased 60 basis points Diluted earnings per share of $0.49 increased 11.4%, Adjusted Diluted Earnings Per Share of $0.56 increased 14.3% Adjusted EBITDA of $217 million increased 18.6%, Adjusted EBITDA margin of 27.7% expanded 270 basis points Announcing a restructuring initiative to reduce expenses Strengthening full-year financial outlook UL Solutions Inc. (NYSE:ULS), a global safety science leader in independent third-party testing, inspection and certif

    11/4/25 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Sets Date for Third Quarter 2025 Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the third quarter 2025 before the market opens on Tuesday, Nov. 4. Management will host a webcast and conference call that same day at 8:30 a.m. EST (7:30 a.m. CST) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the conference call will be

    10/21/25 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Announces Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.13 per share. The dividend will be paid on Sept. 8 to shareholders of record as of the close of business on Aug. 29. About UL Solutions A global leader in applied safety science, UL Solutions (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves a

    8/19/25 4:15:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/13/24 12:26:41 PM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 5:49:12 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form SC 13G filed by UL Solutions Inc.

    SC 13G - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 10:34:15 AM ET
    $ULS
    Precision Instruments
    Health Care